ArticleJAAD case reports2025
Combination therapy including dupilumab, omalizumab, and mycophenolate mofetil for refractory bullous pemphigoid.
Kayadri Ratnarajah et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it